Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.56 |
| ▸ | MAOA | P21397 | 5/20 | 0.56 |
| ▸ | MAPT | P10636 | 4/20 | 0.56 |
| ▸ | HPGD | P15428 | 3/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.56 |
| ▸ | CASP1 | P29466 | 1/20 | 0.56 |
| ▸ | CASP7 | P55210 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | AHR | P35869 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | NQO1 | P15559 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL195537 | 1.00 | ALDH1A1 (0.56) | ALDH1A1KDM4EMAOAMAPTHPGD | |
| Dibenzofuran SCHEMBL9868133 | 0.82 | MAPT (0.68) | ALDH1A1KDM4EMAOAMAPTHPGD | |
| Dibenzofuran SCHEMBL29635704 | 0.82 | MAPT (0.68) | ALDH1A1KDM4EMAOAMAPTHPGD | |
| Dibenzofuran SCHEMBL8207 | 0.82 | MAPT (0.68) | ALDH1A1KDM4EMAOAMAPTHPGD | |
| SCHEMBL6436055 | 0.82 | MAOA (0.64) | ALDH1A1KDM4EMAOAMAPTHPGD | |
| SCHEMBL11634806 | 0.82 | GABRP (0.45) | ALDH1A1KDM4EMAOAMAPTHPGD | |
| SCHEMBL1258329 | 0.82 | MAOB (0.50) | ALDH1A1KDM4EMAOAMAPTHPGD | |
| SCHEMBL11573807 | 0.82 | TNKS (0.45) | ALDH1A1KDM4EMAOAMAPTHPGD | |
| SCHEMBL17115265 | 0.82 | IDO1 (0.43) | ALDH1A1KDM4EMAOAMAPTHPGD | |
| SCHEMBL9851903 | 0.82 | AHR (0.47) | ALDH1A1KDM4EMAOAMAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240240139-A1 | METHODS AND AGRICULTURAL COMPOSITIONS FOR PREVENTING OR CONTROLLING PLANT DISEASES | Bayer CropScience LLC | 2024-07-18 | — | — | US | claimed |
| WO-2025217017-A1 | COMPOSITIONS AND METHODS FOR INCREASING PHOSPHOROUS AVAILABILITY | NOVOZYMES A/S (US) | 2025-10-16 | — | — | WO | disclosed |
| US-20250311734-A1 | Compositions and Methods for Preventing, Treating, Suppressing and/or Eliminatting Phytopathogenic Infestations and Infections | NOVOZYMES A/S (DK) | 2025-10-09 | — | — | US | disclosed |
| WO-2025131903-A1 | PRIESTIA MEGATERIUM AND USES THEREOF | CHR. HANSEN A/S (DK) | 2025-06-26 | — | — | WO | disclosed |
| US-20250151731-A1 | METHYLOBACTERIUM COMPOSITIONS FOR FUNGAL DISEASE CONTROL | NEWLEAF SYMBIOTICS, INC. | 2025-05-15 | — | — | US | disclosed |
| EP-4525615-A2 | COMPOSITIONS AND METHODS FOR PREVENTING, TREATING, SUPRESSING AND/OR ELIMINATING PHYTOPATHOGENIC INFESTATIONS AND INFECTIONS | Novozymes A/S (DK) | 2025-03-26 | — | — | EP | disclosed |
| CN-118436740-B | Traditional Chinese medicine composition and traditional Chinese medicine preparation for reducing uric acid as well as preparation methods and application of traditional Chinese medicine composition and traditional Chinese medicine preparation | 广州中医药大学(广州中医药研究院) | 2024-12-24 | — | — | CN | disclosed |
| CN-118436740-A | Traditional Chinese medicine composition and traditional Chinese medicine preparation for reducing uric acid as well as preparation methods and application of traditional Chinese medicine composition and traditional Chinese medicine preparation | 广州中医药大学(广州中医药研究院) | 2024-08-06 | — | — | CN | disclosed |
| US-20240245055-A1 | METHYLOBACTERIUM COMPOSITIONS FOR FUNGAL DISEASE CONTROL | NEWLEAF SYMBIOTICS, INC. (US) | 2024-07-25 | — | — | US | disclosed |
| US-20240240139-A1 | METHODS AND AGRICULTURAL COMPOSITIONS FOR PREVENTING OR CONTROLLING PLANT DISEASES | Bayer CropScience LLC | 2024-07-18 | — | — | US | disclosed |
| US-11930822-B2 | Methylobacterium compositions for fungal disease control | NEWLEAF SYMBIOTICS, INC. (US) | 2024-03-19 | — | — | US | disclosed |
| US-11920125-B2 | Methods and agricultural compositions for preventing or controlling plant diseases | Tenfold Technologies, LLC (US) | 2024-03-05 | — | — | US | disclosed |
| EP-4293129-A2 | METHODS AND AGRICULTURAL COMPOSITIONS FOR PREVENTING OR CONTROLLING PLANT DISEASES | Tenfold Technologies, LLC (US) | 2023-12-20 | — | — | EP | disclosed |
| WO-2023225459-A2 | COMPOSITIONS AND METHODS FOR PREVENTING, TREATING, SUPRESSING AND/OR ELIMINATING PHYTOPATHOGENIC INFESTATIONS AND INFECTIONS | NOVOZYMES A/S (DK) | 2023-11-23 | — | — | WO | disclosed |
| US-20230133398-A1 | METHODS AND AGRICULTURAL COMPOSITIONS FOR PREVENTING OR CONTROLLING PLANT DISEASES | BAYER CROPSCIENCE LP | 2023-05-04 | — | — | US | disclosed |
| EP-4169364-A1 | METHYLOBACTERIUM COMPOSITIONS FOR FUNGAL DISEASE CONTROL | NewLeaf Symbiotics, Inc. (US) | 2023-04-26 | — | — | EP | disclosed |
| CN-113024534-B | 2-pyridylthiazole derivatives and use thereof | 武汉光谷亚太医药研究院有限公司 | 2023-03-21 | — | — | CN | disclosed |
| EP-3550955-B1 | METHYLOBACTERIUM COMPOSITIONS FOR FUNGAL DISEASE CONTROL | NEWLEAF SYMBIOTICS INC (US) | 2022-10-19 | — | — | EP | disclosed |
| US-20220304311-A1 | METHYLOBACTERIUM COMPOSITIONS FOR FUNGAL DISEASE CONTROL | NEWLEAF SYMBIOTICS, INC. (US) | 2022-09-29 | — | — | US | disclosed |
| US-11284622-B2 | Methylobacterium compositions for fungal disease control | NEWLEAF SYMBIOTICS, INC. (US) | 2022-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250311734-A1 | Compositions and Methods for Preventing, Treating, Suppressing and/or Eliminatting Phytopathogenic Infestations and Infections | RNGTT, PPA1, NOP2 | ALDH1A1 4089/4885KDM4E 4615/4885MAOA 1886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.